Women talking

People with a pathogenic variant in these genes are at a higher risk of developing breast, ovarian or other cancers. Genetic testing for the BRCA1 and BRCA2 pathogenic variants—through a blood sample—can provide further information about your risk for developing breast, ovarian or other cancers.

 

BRCA Infographic

Who Should Consider BRCA Screening?

According to the National Comprehensive Cancer Network (NCCN) recommendations, BRCA testing is suggested for individuals with a personal or family history of any of the following:

  • Early-onset breast cancer (<50 years of age), bilateral breast cancer or triple negative (PR/ER/HER2 negative) breast cancer (<60 years of age)
  • Two primary breast cancers or a diagnosis of both breast and ovarian cancer in one individual
  • Personal or family history of male breast cancer
  • Ovarian cancer at any age
  • Ethnicity with a higher mutation frequency (eg. Ashkenazi Jewish)

Test Details:

This BRCA1/2 screening option will detect 80% of the known pathogenic variants related to Hereditary Breast and Ovarian Cancer syndrome.

Detection:

Analytical Sensitivity: ~99%.
Clinical Sensitivity: Unknown.

Test Results

Turn around time: Results can be expected 3 weeks from the time the sample is received at the laboratory.

Findings are classified as pathogenic, likely pathogenic, benign, likely benign, or variants of unknown significance. Variants of unknown significance may require further studies of the patient and/or family members.

Learn more about why NTD Eurofins has been the laboratory to trust for over 30 years.

Learn More
Trust

BRCA screening is performed through our sister laboratory, EGL Genetics Eurofins.
EGL Genetics has been providing superior, cutting-edge service for more than 47 years. Their expertise spans common and rare genetic disease testing, genomic variant interpretation, test development, and research. EGL Genetics is a CLIA-certified and CAP-accredited laboratory. They work with clients across the United States and from more than 45 countries to help improve patient diagnosis.

Our Goal is to Educate and Empower

Know your choices, understand your options, and talk you your healthcare provider about the best prenatal screening program for you.

Learn More